Ensembl ID ENSG00000104517 Gene ID 51366 Accession 16806
Gene Symbol UBR5 Alias DD5;EDD;HYD;EDD1 Full Name ubiquitin protein ligase E3 component n-recognin 5
Position 8 : 102252273 - 102412759 Length 160487 bases Strand Minus strand
Status Confidence Main interacting RNAsN.A.RBP type Canonical_RBPs
Summary This gene encodes a progestin-induced protein, which belongs to the HECT (homology to E6-AP carboxyl terminus) family. The HECT family proteins function as E3 ubiquitin-protein ligases, targeting specific proteins for ubiquitin-mediated proteolysis. This gene is localized to chromosome 8q22 which is disrupted in a variety of cancers. This gene potentially has a role in regulation of cell proliferation or differentiation. [provided by RefSeq, Jul 2008]

ENSG00000104517 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000104517 UBR5 0.52 6.60e-12 LUSC
ENSG00000104517 UBR5 0.63 2.16e-12 LIHC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000104517 UBR5 cancers 10030672
ENSG00000104517 UBR5 tumor 11309285
ENSG00000104517 UBR5 cancers 12011095
ENSG00000104517 UBR5 cancer 12902990
ENSG00000104517 UBR5 tumor 14871824
ENSG00000104517 UBR5 cancers 15282321
ENSG00000104517 UBR5 tumor 1626955
ENSG00000104517 UBR5 stomach cancer 16721783
ENSG00000104517 UBR5 cancers 17074762
ENSG00000104517 UBR5 cancer 17402705
ENSG00000104517 UBR5 tumor 18047743
ENSG00000104517 UBR5 cancer 18073532
ENSG00000104517 UBR5 tumor 18076571
ENSG00000104517 UBR5 epithelial ovarian cancer 18349819
ENSG00000104517 UBR5 cancers 18425214
ENSG00000104517 UBR5 tumor 20096703
ENSG00000104517 UBR5 breast cancer 20544796
ENSG00000104517 UBR5 cancer 21118991
ENSG00000104517 UBR5 breast cancer 21383020
ENSG00000104517 UBR5 tumor 21665252
ENSG00000104517 UBR5 ovarian cancer 21924388
ENSG00000104517 UBR5 cancers 21949371
ENSG00000104517 UBR5 breast cancer 22242164
ENSG00000104517 UBR5 breast cancer 22666407
ENSG00000104517 UBR5 breast cancer 22695613
ENSG00000104517 UBR5 cancers 23069210
ENSG00000104517 UBR5 tumor 23499005
ENSG00000104517 UBR5 cancer 23847653
ENSG00000104517 UBR5 tumours 23878065
ENSG00000104517 UBR5 breast cancer 24145130
ENSG00000104517 UBR5 breast cancer 24189493
ENSG00000104517 UBR5 epithelial ovarian cancer 24379240
ENSG00000104517 UBR5 breast cancer 24441042
ENSG00000104517 UBR5 cancer 24563673
ENSG00000104517 UBR5 tumors 25886003
ENSG00000104517 UBR5 tumour 26136413
ENSG00000104517 UBR5 tumor 26234678
ENSG00000104517 UBR5 Cancer 26464214
ENSG00000104517 UBR5 HNSCC 26572163
ENSG00000104517 UBR5 tumor 26968484
ENSG00000104517 UBR5 gastric cancer 27124677
ENSG00000104517 UBR5 cancer 27185398
ENSG00000104517 UBR5 gastric cancer 27341561
ENSG00000104517 UBR5 cervical cancer 27446260
ENSG00000104517 UBR5 gastric cancer 27590582
ENSG00000104517 UBR5 ovarian cancer 27721409
ENSG00000104517 UBR5 tumors 28223694
ENSG00000104517 UBR5 tumor 28330927
ENSG00000104517 UBR5 ovarian cancer 28332316
ENSG00000104517 UBR5 colorectal cancers 28689657
ENSG00000104517 UBR5 Colorectal Cancer 28856538
ENSG00000104517 UBR5 breast cancer 28977883
ENSG00000104517 UBR5 cancer 29296225
ENSG00000104517 UBR5 tumor 29344267
ENSG00000104517 UBR5 cancer 29441057
ENSG00000104517 UBR5 colon cancer 29441938
ENSG00000104517 UBR5 ovarian cancer 29607295
ENSG00000104517 UBR5 cancer 29742019
ENSG00000104517 UBR5 tumor 29944885
ENSG00000104517 UBR5 Cancer 30172261
ENSG00000104517 UBR5 cancer 30416686
ENSG00000104517 UBR5 cancer 30598114
ENSG00000104517 UBR5 tumor 30775814
ENSG00000104517 UBR5 tumor 30804124
ENSG00000104517 UBR5 cancer 30894683
ENSG00000104517 UBR5 breast cancer 31392083
ENSG00000104517 UBR5 prostate cancer 31472148
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000104517 UBR5 esophageal adenocarcinoma sequence_alteration 9.132% (40/438) 1 entry
ENSG00000104517 UBR5 esophageal adenocarcinoma frameshift_variant 9.132% (40/438) 1 entry
ENSG00000104517 UBR5 Mantle cell lymphoma stop_gained 12.95% (25/193) 2 entries
ENSG00000104517 UBR5 colorectal adenocarcinoma sequence_alteration 10.11% (126/1246) 2 entries
ENSG00000104517 UBR5 esophageal adenocarcinoma missense_variant 9.132% (40/438) 1 entry
ENSG00000104517 UBR5 breast ductal adenocarcinoma sequence_alteration 13.97% (102/730) 1 entry
ENSG00000104517 UBR5 melanoma missense_variant 13.86% (14/101) 2 entries
ENSG00000104517 UBR5 Mantle cell lymphoma frameshift_variant 12.95% (25/193) 2 entries
ENSG00000104517 UBR5 colorectal adenocarcinoma stop_gained 10.11% (126/1246) 2 entries
ENSG00000104517 UBR5 colorectal adenocarcinoma missense_variant 10.11% (126/1246) 6 entries
ENSG00000104517 UBR5 HER2 Positive Breast Carcinoma missense_variant 12.58% (20/159) 2 entries
ENSG00000104517 UBR5 colorectal adenocarcinoma frameshift_variant 10.11% (126/1246) 3 entries
ENSG00000104517 UBR5 Mantle cell lymphoma missense_variant 12.95% (25/193) 3 entries
ENSG00000104517 UBR5 melanoma frameshift_variant 13.86% (14/101) 1 entry
ENSG00000104517 UBR5 Mantle cell lymphoma sequence_alteration 12.95% (25/193) 2 entries
ENSG00000104517 UBR5 breast ductal adenocarcinoma missense_variant 13.97% (102/730) 1 entry
ENSG00000104517 UBR5 prostate adenocarcinoma missense_variant 4.883% (71/1454) 1 entry
ENSG00000104517 UBR5 head and neck squamous cell carcinoma sequence_alteration 2.011% (15/746) 1 entry
ENSG00000104517 UBR5 cecum adenocarcinoma stop_gained 11.36% (15/132) 1 entry
ENSG00000104517 UBR5 gastric adenocarcinoma frameshift_variant 4.15% (32/771) 2 entries
ENSG00000104517 UBR5 head and neck squamous cell carcinoma missense_variant 2.011% (15/746) 2 entries
ENSG00000104517 UBR5 Dysplasia in Ulcerative Colitis missense_variant 25.0% (2/8) 1 entry
ENSG00000104517 UBR5 prostate carcinoma missense_variant 3.099% (15/484) 1 entry
ENSG00000104517 UBR5 prostate adenocarcinoma stop_gained 4.883% (71/1454) 1 entry
ENSG00000104517 UBR5 female breast carcinoma missense_variant 3.069% (12/391) 3 entries
ENSG00000104517 UBR5 pancreatic ductal adenocarcinoma missense_variant 5.163% (65/1259) 2 entries
ENSG00000104517 UBR5 Merkel cell skin cancer missense_variant 10.0% (3/30) 1 entry
ENSG00000104517 UBR5 ovarian serous adenocarcinoma missense_variant 1.189% (8/673) 1 entry
ENSG00000104517 UBR5 Cervical Small Cell Carcinoma missense_variant 50.0% (3/6) 1 entry
ENSG00000104517 UBR5 bladder transitional cell carcinoma missense_variant 2.92% (4/137) 2 entries
ENSG00000104517 UBR5 non-small cell lung carcinoma missense_variant 8.257% (9/109) 3 entries
ENSG00000104517 UBR5 bile duct adenocarcinoma missense_variant 1.058% (2/189) 1 entry
ENSG00000104517 UBR5 esophageal squamous cell carcinoma frameshift_variant 3.259% (22/675) 2 entries
ENSG00000104517 UBR5 gastric adenocarcinoma sequence_alteration 4.15% (32/771) 1 entry
ENSG00000104517 UBR5 ovarian serous adenocarcinoma sequence_alteration 1.189% (8/673) 2 entries
ENSG00000104517 UBR5 esophageal squamous cell carcinoma stop_gained 3.259% (22/675) 3 entries
ENSG00000104517 UBR5 hepatocellular carcinoma missense_variant 2.323% (22/947) 2 entries
ENSG00000104517 UBR5 nasopharyngeal squamous cell carcinoma missense_variant 1.198% (2/167) 1 entry
ENSG00000104517 UBR5 lung adenocarcinoma stop_gained 3.273% (40/1222) 2 entries
ENSG00000104517 UBR5 clear cell renal carcinoma missense_variant 1.379% (19/1378) 2 entries
ENSG00000104517 UBR5 basal cell carcinoma missense_variant 10.34% (6/58) 1 entry
ENSG00000104517 UBR5 colon adenocarcinoma sequence_alteration 5.867% (45/767) 3 entries
ENSG00000104517 UBR5 large cell lung carcinoma missense_variant 11.11% (2/18) 1 entry
ENSG00000104517 UBR5 alveolar rhabdomyosarcoma missense_variant 3.39% (2/59) 2 entries
ENSG00000104517 UBR5 basal cell carcinoma sequence_alteration 10.34% (6/58) 1 entry
ENSG00000104517 UBR5 colon adenocarcinoma stop_gained 5.867% (45/767) 4 entries
ENSG00000104517 UBR5 brain glioblastoma missense_variant 0.324% (3/926) 1 entry
ENSG00000104517 UBR5 clear cell renal carcinoma sequence_alteration 1.379% (19/1378) 1 entry
ENSG00000104517 UBR5 skin melanoma missense_variant 4.033% (39/967) 6 entries
ENSG00000104517 UBR5 metaplastic breast carcinoma missense_variant 7.843% (4/51) 1 entry
ENSG00000104517 UBR5 chronic lymphocytic leukemia missense_variant 1.014% (9/888) 2 entries
ENSG00000104517 UBR5 skin melanoma sequence_alteration 4.033% (39/967) 2 entries
ENSG00000104517 UBR5 prostate carcinoma sequence_alteration 3.099% (15/484) 1 entry
ENSG00000104517 UBR5 adenosquamous lung carcinoma missense_variant 27.27% (3/11) 1 entry
ENSG00000104517 UBR5 gastric adenocarcinoma missense_variant 4.15% (32/771) 4 entries
ENSG00000104517 UBR5 colon adenocarcinoma frameshift_variant 5.867% (45/767) 3 entries
ENSG00000104517 UBR5 colon adenocarcinoma missense_variant 5.867% (45/767) 5 entries
ENSG00000104517 UBR5 breast carcinoma missense_variant 1.843% (26/1411) 2 entries
ENSG00000104517 UBR5 cecum adenocarcinoma missense_variant 11.36% (15/132) 1 entry
ENSG00000104517 UBR5 esophageal squamous cell carcinoma missense_variant 3.259% (22/675) 5 entries
ENSG00000104517 UBR5 cecum adenocarcinoma frameshift_variant 11.36% (15/132) 2 entries
ENSG00000104517 UBR5 papillary renal cell carcinoma missense_variant 0.597% (2/335) 1 entry
ENSG00000104517 UBR5 gastric intestinal type adenocarcinoma frameshift_variant 11.76% (10/85) 2 entries
ENSG00000104517 UBR5 small cell lung carcinoma missense_variant 1.548% (5/323) 3 entries
ENSG00000104517 UBR5 bladder carcinoma missense_variant 6.306% (35/555) 1 entry
ENSG00000104517 UBR5 prostate adenocarcinoma sequence_alteration 4.883% (71/1454) 2 entries
ENSG00000104517 UBR5 oral squamous cell carcinoma missense_variant 2.927% (6/205) 4 entries
ENSG00000104517 UBR5 gastric intestinal type adenocarcinoma missense_variant 11.76% (10/85) 2 entries
ENSG00000104517 UBR5 ovarian carcinoma missense_variant 40.0% (4/10) 1 entry
ENSG00000104517 UBR5 Ampulla of Vater Carcinoma missense_variant 2.353% (2/85) 1 entry
ENSG00000104517 UBR5 clear cell renal carcinoma frameshift_variant 1.379% (19/1378) 1 entry
ENSG00000104517 UBR5 lung adenocarcinoma missense_variant 3.273% (40/1222) 8 entries
ENSG00000104517 UBR5 squamous cell lung carcinoma missense_variant 2.4% (21/875) 4 entries
ENSG00000104517 UBR5 rectal adenocarcinoma missense_variant 1.762% (4/227) 2 entries
ENSG00000104517 UBR5 ulcerative colitis missense_variant 11.11% (1/9) 1 entry
ENSG00000104517 UBR5 osteosarcoma frameshift_variant 1.724% (2/116) 1 entry
ENSG00000104517 UBR5 oral squamous cell carcinoma frameshift_variant 2.927% (6/205) 1 entry
ENSG00000104517 UBR5 skin carcinoma missense_variant 4.808% (5/104) 1 entry
ENSG00000104517 UBR5 female breast carcinoma stop_gained 3.069% (12/391) 1 entry
ENSG00000104517 UBR5 diffuse gastric adenocarcinoma missense_variant 1.266% (1/79) 1 entry
ENSG00000104517 UBR5 Pancreatic Acinar Cell Carcinoma sequence_alteration 15.0% (3/20) 1 entry
ENSG00000104517 UBR5 endometrial stromal sarcoma missense_variant 8.333% (1/12) 1 entry
ENSG00000104517 UBR5 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma sequence_alteration 16.67% (1/6) 1 entry
ENSG00000104517 UBR5 bladder transitional cell carcinoma sequence_alteration 2.92% (4/137) 1 entry
ENSG00000104517 UBR5 skin melanoma frameshift_variant 4.033% (39/967) 1 entry
ENSG00000104517 UBR5 gastric intestinal type adenocarcinoma sequence_alteration 11.76% (10/85) 1 entry
ENSG00000104517 UBR5 Ocular Sebaceous Carcinoma stop_gained 4.348% (1/23) 1 entry
ENSG00000104517 UBR5 Brain Stem Glioblastoma frameshift_variant 3.571% (2/56) 1 entry
ENSG00000104517 UBR5 bronchoalveolar adenocarcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000104517 UBR5 endometrial carcinoma stop_gained 4.348% (1/23) 1 entry
ENSG00000104517 UBR5 Pancreatic Acinar Cell Carcinoma frameshift_variant 15.0% (3/20) 1 entry
ENSG00000104517 UBR5 basal cell carcinoma stop_gained 10.34% (6/58) 1 entry
ENSG00000104517 UBR5 neoplasm missense_variant 7.143% (2/28) 1 entry
ENSG00000104517 UBR5 ovarian mucinous adenocarcinoma missense_variant 7.692% (1/13) 1 entry
ENSG00000104517 UBR5 endometrial carcinoma missense_variant 4.348% (1/23) 1 entry
ENSG00000104517 UBR5 adenosquamous lung carcinoma sequence_alteration 27.27% (3/11) 1 entry
ENSG00000104517 UBR5 medullary thyroid gland carcinoma sequence_alteration 5.263% (1/19) 1 entry
ENSG00000104517 UBR5 small cell lung carcinoma stop_gained 1.548% (5/323) 1 entry
ENSG00000104517 UBR5 female breast carcinoma frameshift_variant 3.069% (12/391) 1 entry
ENSG00000104517 UBR5 Merkel cell skin cancer sequence_alteration 10.0% (3/30) 1 entry
ENSG00000104517 UBR5 large cell lung carcinoma stop_gained 11.11% (2/18) 1 entry
ENSG00000104517 UBR5 lung adenocarcinoma sequence_alteration 3.273% (40/1222) 1 entry
ENSG00000104517 UBR5 lung adenocarcinoma conservative_inframe_deletion 3.273% (40/1222) 1 entry
ENSG00000104517 UBR5 Testicular Non-Seminomatous Germ Cell Tumor missense_variant 33.33% (1/3) 1 entry
ENSG00000104517 UBR5 acute lymphoblastic leukemia missense_variant 0.3115% (1/321) 1 entry
ENSG00000104517 UBR5 head and neck squamous cell carcinoma frameshift_variant 2.011% (15/746) 1 entry
ENSG00000104517 UBR5 osteosarcoma sequence_alteration 1.724% (2/116) 1 entry
ENSG00000104517 UBR5 nodular melanoma missense_variant 50.0% (1/2) 1 entry
ENSG00000104517 UBR5 ovarian neoplasm sequence_alteration 1.724% (1/58) 1 entry
ENSG00000104517 UBR5 Endometrial Clear Cell Adenocarcinoma missense_variant 8.333% (1/12) 1 entry
ENSG00000104517 UBR5 rectal adenocarcinoma frameshift_variant 1.762% (4/227) 1 entry
ENSG00000104517 UBR5 gastric intestinal type adenocarcinoma stop_gained 11.76% (10/85) 1 entry
ENSG00000104517 UBR5 embryonal rhabdomyosarcoma missense_variant 1.316% (1/76) 1 entry
ENSG00000104517 UBR5 non-small cell lung carcinoma stop_gained 8.257% (9/109) 1 entry
ENSG00000104517 UBR5 ependymoma sequence_alteration 2.174% (1/46) 1 entry
ENSG00000104517 UBR5 Brain Stem Glioblastoma sequence_alteration 3.571% (2/56) 1 entry
ENSG00000104517 UBR5 Pancreatic Acinar Cell Carcinoma missense_variant 15.0% (3/20) 1 entry
ENSG00000104517 UBR5 squamous cell lung carcinoma stop_gained 2.4% (21/875) 1 entry
ENSG00000104517 UBR5 squamous cell lung carcinoma sequence_alteration 2.4% (21/875) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000104517 UBR5 SARC 0.0059 high
ENSG00000104517 UBR5 CHOL 0.016 low
ENSG00000104517 UBR5 PAAD 0.0069 high
ENSG00000104517 UBR5 UCEC 0.015 high
ENSG00000104517 UBR5 THCA 0.018 high
ENSG00000104517 UBR5 ACC 0.0073 high
ENSG00000104517 UBR5 READ 0.02 low
ENSG00000104517 UBR5 KIRP 0.0018 high
ENSG00000104517 UBR5 BRCA 0.0025 high
ENSG00000104517 UBR5 OV 0.0013 high
ENSG00000104517 UBR5 KIRC 0.0032 low
ENSG00000104517 UBR5 PRAD 0.016 high
ENSG00000104517 UBR5 LAML 0.0023 low
ENSG00000104517 UBR5 GBM 0.0094 low
ENSG00000104517 UBR5 CESC 0.0053 high
ENSG00000104517 UBR5 LIHC 0.00011 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000104517 UBR5 LUSC Amp 1.606156 0.223943 0.534604 0.614770
ENSG00000104517 UBR5 LUAD Amp 6.368217 0.224836 0.619110 0.571705
ENSG00000104517 UBR5 LGG Amp 8.825532 0.139870 0.685714 0.173489
ENSG00000104517 UBR5 CESC Amp 1.178795 0.147852 0.627227 0.376271
ENSG00000104517 UBR5 READ Amp 2.676555 0.218858 0.803269 0.630303
ENSG00000104517 UBR5 COAD Amp 4.353856 0.130649 0.781568 0.560976
ENSG00000104517 UBR5 UCS Amp 0.751957 0.502100 1.129011 0.696429
ENSG00000104517 UBR5 ESCA Amp 2.858331 0.380982 0.655419 0.684783
ENSG00000104517 UBR5 SKCM Amp 1.047724 0.131787 0.764406 0.490463
ENSG00000104517 UBR5 HNSC Amp 3.037288 0.168374 0.576802 0.695402
ENSG00000104517 UBR5 LIHC Amp 13.983360 0.343606 1.165976 0.616216
ENSG00000104517 UBR5 BLCA Amp 31.204196 0.715251 0.917981 0.629902
ENSG00000104517 UBR5 BRCA Amp 42.322786 0.501759 1.058646 0.612963
ENSG00000104517 UBR5 STAD Amp 4.974511 0.236988 0.623989 0.637188
ENSG00000104517 UBR5 PRAD Amp 3.850748 0.089033 0.711970 0.321138
ENSG00000104517 UBR5 UCEC Amp 0.727589 0.103400 0.758952 0.339518
ENSG00000104517 UBR5 UVM Amp 9.477347 0.581109 1.507945 0.750000
ENSG00000104517 UBR5 KICH Amp 0.662421 0.210601 0.966492 0.287879
ENSG00000104517 UBR5 OV Amp 20.756845 0.705948 0.973693 0.625216